Dr. Hartman has over 15 years of research and development experience in a range of disciplines, including oncology, stem cell biology, toxicology, and regenerative medicine in both academic and industry settings. She is focused on identifying and developing novel product applications for cellular and genomics workflows for the CellRaft Technology. She most recently served as the Director of Cell-Based Assay Development at ScitoVation. Dr. Hartman received a Ph.D. in Molecular Cancer Biology from Duke University and holds a Bachelor of Science degree in Biology from the University of Virginia.